Emergent BioSolutions Inc receives J&J’s COVID-19 vaccine order for $23M

Late of Sunday, Emergent BioSolutions Inc said, a key U.S. agency has increased an order related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million.

“The amount will be used to purchase biologics equipment specific to J&J’s vaccine and support the potential manufacturing expansion at the company’s Baltimore Bayview facility,” said the company in a statement while adding, ramping up manufacturing of AstraZeneca Plc’s COVID-19 vaccine bulk drug substance, is also on the cards.

Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: